Abstract

A positive resection margin is considered to be a factor associated with poor prognosis after pancreatic ductal adenocarcinoma resection. However, analysis of the resection margin is dependent on the pathological slicing technique. The aim of this systematic review and meta-analysis was to study the impact of resection margin on the survival of pancreatic ductal adenocarcinoma patients whose specimens were analyzed using the axial slicing technique. A systematic search in the PubMed, Cochrane, and Embase datasets covering the time period from November 2006 to January 2019 was performed. Only studies with axial slicing technique (Leeds Pathology Protocol or Royal College of Pathology Protocol) were included in the final database. Meta-analysis between the marginal distance and survival was performed with the Inverse Variance Method in RevMan. The systematic search resulted in nine studies meeting the inclusion criteria. The median survival for a resection margin 0 mm ranged from 12.3 to 23.4 months, for resection margin <0.5 mm 16 months, for resection margin <1 mm ranged from 11 to 27.5 months, for resection margin <1.5 mm ranged from 16.9 to 21.2 months, and for resection margin >2 mm ranged from 53.9 to 63.1 months. Five studies were eligible for meta-analysis. The pooled multivariable hazard ratio favored resection margin ⩾1 mm (hazard ratio: 1.32 and 95% confidence interval: 1.03-1.68, p = 0.03). Resection margins ⩾1 mm seem to lead to better survival in pancreatic ductal adenocarcinoma patients than resection margin <1 mm. However, there is not enough data to evaluate the effect of oncologic therapy or to analyze the impact of other resection margin distances on survival.

Highlights

  • A study of 28 European Union (EU) countries predicts that pancreatic cancer may become the third leading cause of cancer-related death in the EU after lung and colorectal cancers, in contrast to stable or even declining trends for most cancer types [1]

  • The pooled multivariable hazard ratio favored resection margin ⩾1 mm

  • Resection margins ⩾1 mm seem to lead to better survival in pancreatic ductal adenocarcinoma patients than resection margin

Read more

Summary

Introduction

A study of 28 European Union (EU) countries predicts that pancreatic cancer may become the third leading cause of cancer-related death in the EU after lung and colorectal cancers, in contrast to stable or even declining trends for most cancer types [1]. The International Study Group of Pancreatic Surgery (ISGPS) [2], Royal College of Pathologists [3], and the College of American Pathologists (CAP) [4] suggested an RM of at least 1 mm, while the International Union Against Cancer (UICC) [5] claims that an RM of 0 mm would suffice. To study the impact of RM on survival among pancreatic ductal adenocarcinoma (PDAC) patients, we conducted a systematic review and a meta-analysis including only studies analyzing pathological samples with axial slicing techniques: Leeds Pathology Protocol (LEEPP) or Royal College of Pathology Protocol (RCP). A positive resection margin is considered to be a factor associated with poor prognosis after pancreatic ductal adenocarcinoma resection. The aim of this systematic review and meta-analysis was to study the impact of resection margin on the survival of pancreatic ductal adenocarcinoma patients whose specimens were analyzed using the axial slicing technique

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.